In comparison to defects in BH4 biosynthesis, patients with inborn variants of QDPR present a higher frequency of severe neurological symptoms, including muscular hypotonia, dystonia, microcephaly, epilepsy and brain atrophy [11, 12]. This evidence concerns the gene QDPR and microcephaly.